Alexandria Pharmaceuticals and Chemical Industries (AXPH)

Last update: 01:14 PM market time.

572.24

13.56

2.43%

Open 558.68

Previous Close 558.68

High 614.00

Low 557.02

Stock Statistics

Volume 5,813

Turnover 3,386,991.75

All data are 15 minutes late during market session

News

Photo Archive

10 April 2022 03:08 PM Alexandria Pharmaceuticals’ profits retreat 25% in 8M-21/22

Cairo – Mubasher: Alexandria Pharmaceuticals and Chemical Industries posted an annual decrease of 25.24% in net profits after tax during the period from July 2021 to February 2022. The company logged net profits after tax worth EGP 71.25 million …

Financial Results

Photo Archive

10 March 2022 09:43 AM Alexandria Pharmaceuticals profits fall 22.5% in 7M-21/22

Cairo – Mubasher: The net profits after tax of Alexandria Pharmaceuticals and Chemical Industries declined by 22.50% year-on-year (YoY) during the period from July 2021 to January 2022. The company logged net profits worth EGP 66.01 million in the …

Financial Results

Photo Archive

6 February 2022 08:39 AM Alexandria Pharmaceuticals posts 27% lower profits in 6M

Cairo – Mubasher: The net profits of Alexandria Pharmaceuticals and Chemical Industries has reported a 27.25% year-on-year (YoY) decrease in net profits to EGP 57.32 million in the first half (H1) of fiscal year 2021/2022, compared to EGP 79 …

Financial Results

Photo Archive

19 December 2021 09:39 AM Alexandria Pharmaceuticals reports 34% lower profits in 4M

Cairo – Mubasher: The net profits of Alexandria Pharmaceuticals and Chemical Industries declined by 34.1% to EGP 35.72 million in the first fourth months (4M) of the current fiscal year, compared to EGP 54.28 million in the year-ago period. The …

Financial Results

Photo Archive

17 November 2021 00:01 PM Alexandria Pharmaceuticals targets EGP 129m net profits in FY21/22

Cairo – Mubasher: Alexandria Pharmaceuticals and Chemical Industries plans to achieve net profits after tax worth EGP 129 million during fiscal year (FY) 2021/2022, compared to the EGP 208 million that was approved for the current FY. The targeted …

Financial Results

The pharmaceutical firm recorded net profits of EGP 116.99 million

3 October 2021 00:33 PM Alexandria Pharmaceuticals to pay EGP 10/shr dividend for FY20/21

Cairo – Mubasher: The ordinary general meeting (OGM) of Alexandria Co. for Pharmaceuticals and Chemical Industries approved a cash dividend of EGP 10 per share for fiscal year (FY) 2020/2021. Moreover, the company's shareholders decided to defer …

General Assembly

The sales increased to EGP 1.11 billion in the year ended 30 June

5 September 2021 11:43 AM Alexandria Pharmaceuticals reports 31% profit drop in FY20/21 modified financials

Cairo – Mubasher: Alexandria Co. for Pharmaceuticals and Chemical Industries recorded net profits of EGP 116.99 million in fiscal year (FY) 2020/2021, down by 31.2% year-on-year (YoY) from EGP 170.05 million, the modified financial results …

Financial Results

The transaction involved the sale of 61,170 shares

24 August 2021 08:59 AM Firstrand Bank trims stake in Alexandria Pharmaceuticals

Cairo – Mubasher: Firstrand Bank Ltd has reduced its stake in Alexandria Co. for Pharmaceuticals and Chemical Industries to 2.8% from 5.4%. The transaction involved the sale of 61,170 shares for EGP 8.1 million, averaging EGP 133.02 per share, …

Insider Trading & Treasury Stocks

The sales increased to EGP 1.12 billion in the year ended 30 June

4 August 2021 07:38 AM Alexandria Pharmaceuticals records 23% lower profit in FY20/21

Cairo - Mubasher: Alexandria Co. for Pharmaceuticals and Chemical Industries reported a 22.7% year-on-year (YoY) drop in its net profits to EGP 131.47 million in fiscal year (FY) 2020/2021, compared to EGP 170.05 million, the unaudited financial …

Financial Results

The revenues grew to EGP 971.02 million in the period ended 30 April

2 June 2021 08:01 AM Alexandria Pharmaceuticals posts 21% lower profit in 10 months

Cairo – Mubasher: Alexandria Co. for Pharmaceuticals and Chemical Industries recorded net profits of EGP 118.11 million in the first 10 months of fiscal year (FY) 2020/2021, down by 21% year-on-year (YoY) from EGP 149.6 million. The revenues grew …

Financial Results

The revenues increased to EGP 890.26 million in the period ended 31 March

5 May 2021 09:23 AM Alexandria Pharmaceuticals reports 19.5% lower profit in nine months

Cairo – Mubasher: Alexandria Co. for Pharmaceuticals and Chemical Industries logged net profits of EGP 108.17 million in the first nine months of fiscal year (FY) 2020/2021, down by 19.5% year-on-year (YoY) from EGP 134.37 million, the unaudited …

Financial Results

The pharmaceutical company plans to generate EGP 1.44 billion in revenue

21 February 2021 08:41 AM Alexandria Pharmaceuticals targets EGP 208m profit in FY21/22

Cairo – Mubasher: The board of directors of Alexandria Co. for Pharmaceuticals and Chemical Industries approved the estimated budget for fiscal year 2021/2022. The company aims to achieve EGP 208 million in net profits during the coming fiscal …

The company’s revenues grew to EGP 385.32 million

8 December 2020 08:47 AM Alexandria Pharmaceuticals sees profit edge up in 4M

Cairo – Mubasher: The net profits of Alexandria Co. for Pharmaceuticals and Chemical Industries inched up by 2.8% year-on-year (YoY) to EGP 54.28 million in the first four months of fiscal year 2020/2021, compared to EGP 52.77 million. The …

Financial Results

The company’s revenues increased to EGP 304.39 million

4 November 2020 09:40 AM Alexandria Pharmaceuticals reports 19% higher profit in Q1-20/21

Cairo – Mubasher: The financial indicators of Alexandria Co. for Pharmaceuticals and Chemical Industries showed net profits of EGP 44.95 million in the first quarter (Q1) of fiscal year 2020/2020, up by 18.6% year-on-year (YoY) from EGP 37.87 …

Financial Results

Kahira Pharmaceuticals jumped by 32% in three months

20 October 2020 02:09 PM Pharma stocks lead EGX ahead of potential acquisitions

Cairo – Mubasher: Amid market volatility due to concerns over a second wave of coronavirus (COVID-19) infections, pharmaceutical stocks on the Egyptian Exchange (EGX) reported strong performance ahead of potential mergers and acquisitions. Amr …

Trading Activities

The company's net profits jumped by 51% in FY19/20

26 August 2020 10:08 AM Alexandria Pharmaceuticals proposes EGP 57.5m dividends for FY19/20

Cairo – Mubasher: The board of directors of Alexandria Co. for Pharmaceuticals and Chemical Industries recommended a cash dividend distribution of EGP 11.5 per share for fiscal year 2019/2020. The proposed cash dividends amount to EGP 57.5 …

The company generated EGP 1.02 billion in sales

23 August 2020 10:32 AM Alexandria Pharmaceuticals logs EGP 170m profit in FY19/20 modified financials

Cairo – Mubasher: The modified unaudited financial results of Alexandria Co. for Pharmaceuticals and Chemical Industries reported EGP 170.04 million in net profits during fiscal year 2019/2020, rising by 50.7% year-on-year (YoY) from EGP 112.8 …

Financial Results

The company’s sales increased to EGP 1.02 billion

5 August 2020 08:40 AM Alexandria Pharmaceuticals posts 54% profit hike in FY19/20 initial results

Cairo – Mubasher: The unaudited financial results of Alexandria Co. for Pharmaceuticals and Chemical Industries showed a 54% year-on-year (YoY) growth in its net profits to EGP 173.8 million in fiscal year 2019/2020 from EGP 112.8 million. The …

Financial Results

The company achieved net profits of EGP 150.56 million in 11 months

26 July 2020 10:24 AM Alexandria Pharmaceuticals plans to invest EGP 200m in 2020, 2021

Cairo – Mubasher: Alexandria Co. for Pharmaceuticals and Chemical Industries is looking to inject more that EGP 200 million worth of direct investments into the pharmaceutical and medical supplies market in 2020 and 2021 in Egypt and enter new …

Companies Investments

The company is looking to invest a total of EGP 182 million in FY20/21

23 February 2020 08:34 AM Alexandria Pharmaceuticals targets EGP 196.5m profit in FY20/21

Cairo – Mubasher: Alexandria Pharmaceuticals and Chemical Industries aims to increase its profits by 34% year-on-year during fiscal year 2020/2021. The pharmaceuticals company plans to achieve profits of EGP 196.5 million in the coming fiscal year …

Financial Results

Alexandria Pharmaceuticals's revenues totalled EGP 531.4 million in H1-19/20

2 February 2020 10:57 AM Alexandria Pharmaceuticals records EGP 85m profit in 6M

Cairo – Mubasher: Alexandria Pharmaceuticals and Chemical Industries achieved an increase of 17.9% in net profits during the first six months of fiscal year 2019/2020 when compared to the corresponding period a year earlier. The company registered …

Financial Results

The company’s revenues increased to EGP 255.9 million

4 November 2019 00:39 PM Alexandria Pharmaceuticals’ profit grows 23% in Q1-19/20 unaudited financials

Cairo – Mubasher: The unaudited financial results of Alexandria Pharmaceuticals and Chemical Industries showed a 22.85% year-on-year profit rise during the first quarter of fiscal year 2019/2020. Net profits grew to EGP 37.87 million in the …

Financial Results

The company’s capital stands at EGP 50 million

29 September 2019 00:50 PM Alexandria Pharmaceuticals approves EGP 11.2/shr dividend for FY18/19

Cairo – Mubasher: Alexandria Pharmaceuticals and Chemical Industries announced that its shareholders approved a cash dividend distribution of EGP 11.2 per share for fiscal year 2018/2019 during an ordinary general meeting (OGM). The company’s …

The total value of proposed dividends amounted to EGP 45 million

18 August 2019 08:57 AM Alexandria Pharmaceuticals proposes EGP 9/shr dividends for FY18/19

Cairo – Mubasher: The board of directors of Alexandria Pharmaceuticals and Chemical Industries recommended a cash dividend distribution of EGP 9 per share for fiscal year 2018/2019. The total value of proposed dividends amounted to EGP 45 million, …

Board of Directors

Sales rose to EGP 829 million in FY18/19

18 August 2019 07:57 AM Alexandria Pharmaceuticals’ FY18/19 modified financials post EGP 112.8m profit

Cairo – Mubasher: Alexandria Pharmaceuticals and Chemical Industries reported a slight profit decline on an annual basis during fiscal year 2018/2019, the company’s modified unaudited financial results showed. The pharmaceuticals firm’s profit …

Financial Results